BioAtla
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.About BCAB
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.
CEOJay M. Short
CEOJay M. Short
Employees76
Employees76
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2007
Founded2007
Employees76
Employees76
BCAB Key Statistics
Market cap46.35M
Market cap46.35M
Price-Earnings ratio-0.67
Price-Earnings ratio-0.67
Dividend yield—
Dividend yield—
Average volume887.49K
Average volume887.49K
High today$0.8793
High today$0.8793
Low today$0.7437
Low today$0.7437
Open price$0.8221
Open price$0.8221
Volume1.26M
Volume1.26M
52 Week high$1.47
52 Week high$1.47
52 Week low$0.24
52 Week low$0.24
Stock Snapshot
BioAtla(BCAB) stock is priced at $0.81, giving the company a market capitalization of 46.35M. It carries a P/E multiple of -0.67.
During the trading session on 2025-12-15, BioAtla(BCAB) shares reached a daily high of $0.88 and a low of $0.74. At a current price of $0.81, the stock is +9.5% higher than the low and still -7.4% under the high.
Trading activity shows a volume of 1.26M, compared to an average daily volume of 887.49K.
The stock's 52-week range extends from a low of $0.24 to a high of $1.47.
The stock's 52-week range extends from a low of $0.24 to a high of $1.47.
People also own
Based on the portfolios of people who own BCAB. This list is generated using Robinhood data, and it’s not a recommendation.